Deal Snapshot
ATRICURE TO ACQUIRE HEART DEVICE DEVELOPER SENTREHEART
Tuesday 13 August 2019

US-based atrial fibrillation and left atrial appendage management treatments developer AtriCure, Inc. (NASDAQ: ATRC) has entered into a definitive agreement to acquire SentreHEART, Inc., a privately held developer of percutaneous left atrial appendage management solutions, the company said.
Under the terms of the agreement to acquire SentreHEART, the transaction consideration consists of an upfront payment of approximately USD 40m in cash and AtriCure common stock, plus additional contingent consideration based on the achievement of certain clinical and reimbursement milestones over the next several years, all of which are value-creating events.


TKUqg0 http://www.FyLitCl7Pf7kjQdDUOLQOuaxTXbj5iNG.com
Details
Date Published: 13/08/2019
Target: SentreHEART, Inc
Country: USA
Deal Size: 40m (USD)
Sector: Healthcare
Type: Corporate acquisition
Financing: Cash and Stock
Status: Agreed
Vendor:
Buyer: AtriCure, Inc
Buyer Advisor: Piper Jaffray and Co , Pepper Hamilton LLP
Comment:


Options